|
[1]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Guideline for diagnosis and treatment of liver failure (2018) [J].J Clin Hepatol, 2019, 35 (1) :38-44. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2018年版) [J].临床肝胆病杂志, 2019, 35 (1) :38-44.
|
|
[2]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and treatment of cholestasis liver diseases (2015) [J].J Clin Hepatol, 2015, 31 (12) :1989-1999. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.胆汁淤积性肝病诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1989-1999.
|
|
[3]WATANABE M, FUKIYA S, YOKOTA A.Comprehensive evaluation of the bactericidal activitiesof free bile acids in the large intestine of humans and rodents[J].J Lipid Res, 2017, 58 (6) :1143-1152.
|
|
[4]DEVKOTA S, CHANG EB.Interactions between diet, bile acid metabolism, gut microbiota, and inflammatory bowel diseases[J].Dig Dis, 2015, 33 (3) :351-356.
|
|
[5]GAHAN CG, HILL C.Listeria monocytogenes:Survival and adaptation in the gastrointestinal tract[J].Front Cell Infect Microbiol, 2014, 4:9.
|
|
[6]GERARD P.Metabolism of cholesterol and bile acids by the gut microbiota[J].Pathogens, 2013, 3 (1) :14-24.
|
|
[7]JONES H, ALPINI G, FRANCIS H.Bile acid signaling and biliary functions[J].Acta Pharm Sin B, 2015, 5 (2) :123-128.
|
|
[8]LI Y, TANG R, LEUNGG PSC, et al.Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases[J].Autoimmun Rev, 2017, 16 (9) :885-896.
|
|
[9]CHEN Y, YANG F, LU H, et al.Characterization of fecal microbial communities in patients with liver cirrhosis[J].Hepatology, 2011, 54 (2) :562-572.
|
|
[10]TRAUNER M, FICKERT P, TILG H.Bile acids as modulators of gut microbiota linking dietary habits and inflammatory bowel disease:A potentially dangerous liaison[J].Gastroenterology, 2013, 144 (4) :844-846.
|
|
[11]AVANCINI J, MARAGNO L, SANTI CG, et al.Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome:Clinical features of 27 patients[J].Clin Exp Dermatol, 2015, 40 (8) :851-859.
|
|
[12]MENDIZABAL M, MARCIANO S, VIDELA MG, et al.Fulminant presentation of autoimmune hepatitis:Clinical features and early predictors of corticosteroid treatment failure[J].Eur J Gastroenterol Hepatol, 2015, 27 (6) :644-648.
|
|
[13]LOUVET A, THURSZ MR, KIM DJ, et al.Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials[J].Gastroenterology, 2018, 155 (2) :458-468.
|
|
[14]ZHANG XQ, JIANG L, MAO Q.Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure[J].Hepatol Res, 2011, 41 (1) :46-53.
|
|
[15]GREEN JL, HEARD KJ, REYNOLDS KM, et al.Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity:A systematic review and meta-analysis[J].West J Emerg Med, 2013, 14 (3) :218-226.
|
|
[16]HU J, ZHANG Q, REN X, et al.Efficacy and safety of acetylcysteine in"non-acetaminophen"acute liver failure:A meta-analysis of prospective clinical trials[J].Clin Res Hepatol Gastroenterol, 2015, 39 (5) :594-599.
|
|
[17]SINGH S, HYNAN LS, LEE WM.Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage nonacetaminophen acute liver failure[J].Dig Dis Sci, 2013, 58 (5) :1397-1402.
|
|
[18]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
|
|
[19]BANIASADI S, EFTEKHARI P, TABARSI P, et al.Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity[J].Eur J Gastroenterol Hepatol, 2010, 22 (10) :1235-1238.
|
|
[20]KARVELLAS CJ, CAVAZOS J, BATTENHOUSE H, et al.Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure:A retrospective cohort study[J].Clin Gastroenterol Hepatol, 2014, 12 (11) :1942-1949.
|
|
[21] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.Guideline for non-bioartificial liver support systems in treatment of liver failure:2016 update[J].Chin J Clin Infect Dis, 2016, 9 (2) :97-103. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南 (2016年版) [J].中华临床感染病杂志, 2016, 9 (2) :97-103.
|
|
[22]TILG H, CANI PD, MAYER EA.Gut microbiome and liver diseases[J].Gut, 2016, 65 (12) :2035-2044.
|
DownLoad: